Pharming Group N.V.
PHAR | NASDAQ
$12.23
+$0.10 (+0.82%)
At close: Oct 30, 2026, 4:00 PM ET
$12.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Market Data
Market Cap $865.62M
Enterprise Value $790.57M
Beta 0.09
Average Volume 19.86K
Shares Outstanding (Diluted) 74.67M
Shares Change YoY 11.6%
Institutional Ownership 3.20%
Exchange NASDAQ
ISIN US71716E1055
Price Performance
Price Change 1M 22.4%
Price Change 3M 21.3%
Price Change 6M -28.0%
Price Change YTD -30.8%
Price Change 1Y -6.6%
Price Change 3Y 3.1%
Price Change 5Y 35.9%
1M CAGR (ann.) 15.9%
1Y CAGR (ann.) -8.8%
5Y CAGR (ann.) 5.3%
All-Time CAGR -5.2%
Valuation
PE Ratio 38.22
Forward PE 41.53
PEG Ratio 0.00
Forward PEG 0.04
PS Ratio 2.24
Forward PS 2.20
PB Ratio 2.97
P/FCF Ratio 27.35
P/Adj. FCF Ratio 42.08
P/OCF Ratio 27.18
EV/Sales 2.04
EV/EBIT 21.07
EV/EBITDA 15.92
EV/FCF 24.98
Earnings Yield 2.6%
FCF Yield 3.7%
Adj. FCF Yield 2.4%
Financial Health
Net Cash $86.15M
Total Debt $114.51M
Cash & Short-Term Investments $189.56M
Total Assets $496.64M
Current Ratio 3.23
Quick Ratio 2.65
Debt / Equity Ratio 0.39
Debt / EBITDA 2.31
Debt / FCF 3.62
OCF / Debt 0.28
Interest Coverage 0.02
Altman Z-Score 3.35
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 84.3%
Operating Profit Margin 6.3%
EBITDA Margin 11.1%
Net Profit Margin 6.3%
FCF Margin 8.2%
Adj. FCF Margin 5.3%
SBC / Revenue 2.9%
SBC Impact (per share) -35.0%
Returns
Return on Assets 5.0%
Return on Equity 9.0%
Return on Invested Capital 4.7%
Return on Capital Employed 6.8%
Return on Tangible Assets 6.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 20.9%
Revenue CAGR 5Y 12.7%
Revenue CAGR 10Y 41.5%
EPS CAGR 3Y 729.7%
EPS CAGR 5Y -1.2%
EPS CAGR 10Y 584.5%
FCF CAGR 3Y 57.6%
FCF CAGR 5Y -0.6%
FCF CAGR 10Y -7.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y 4.5%
Revenue Growth Next 3Y 5.5%
Earnings Date Mar 11, 2027
EPS Estimate (next Q) $0.07
EPS Growth Est (next Q) 0.0%
Revenue Est (next Q) $107.55M
Revenue Growth Est (next Q) 1.0%
Fair Value Estimates
Graham Number $5.40
Graham Upside -55.9%
Lynch Fair Value $1.60
Lynch Upside -86.9%
Price Target $39.00
Price Target Upside 218.9%
Cash Flow
Operating Cash Flow $32.52M
Free Cash Flow $31.65M
Adj. Free Cash Flow $20.57M
FCF Per Share $0.43
OCF Per Share $0.45
OCF/S Ratio 8.2%
Income Statement
Revenue $386.64M
Gross Profit $326.19M
Operating Income $24.27M
EBITDA $49.66M
Net Income $24.1M
EPS (Diluted) $0.32
Revenue / Employee $949.97K
Profit / Employee $59.22K
Employees 407
Add to Watchlist
Select watchlists to add or remove PHAR